🇺🇸 Iopanoicum in United States

FDA authorised Iopanoicum on 16 July 1951

Marketing authorisations

FDA — authorised 16 July 1951

  • Status: approved

FDA — authorised 16 July 1951

  • Application: NDA008032
  • Marketing authorisation holder: GE HEALTHCARE
  • Local brand name: TELEPAQUE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Iopanoicum in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Gastroenterology approved in United States

Frequently asked questions

Is Iopanoicum approved in United States?

Yes. FDA authorised it on 16 July 1951; FDA authorised it on 16 July 1951.

Who is the marketing authorisation holder for Iopanoicum in United States?

Marketing authorisation holder not available in our data.